Acadia Pharmaceutica
(ACAD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 226,451 | -61,286 | -215,975 | -167,870 | -281,584 |
| Depreciation Amortization | 6,579 | -1,981 | -710 | 5,748 | 4,402 |
| Accounts receivable | -472 | -36,072 | 2,171 | -16,119 | -12,466 |
| Accounts payable and accrued liabilities | -1,351 | 4,797 | 5,870 | -1,617 | 1,271 |
| Other Working Capital | 4,155 | 18,133 | 37,991 | -24,824 | 11,036 |
| Other Operating Activity | -77,643 | 93,111 | 56,618 | 79,022 | 141,175 |
| Operating Cash Flow | $157,719 | $16,702 | $-114,035 | $-125,660 | $-136,166 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -176,530 | 59,795 | 73,241 | -69,980 | 200,096 |
| PPE Investments | -523 | -50 | N/A | -1,122 | -7,587 |
| Sale Of Investment | N/A | 12,253 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -40,000 | N/A | N/A | N/A |
| Other Investing Activity | 146,515 | -40,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-30,538 | $31,998 | $73,241 | $-71,102 | $192,509 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,845 | 25,129 | 8,199 | 18,162 | 80,996 |
| Financing Cash Flow | $6,845 | $25,129 | $8,199 | $18,162 | $80,996 |
| Exchange Rate Effect | -94 | -18 | 6 | 7 | -8 |
| Beginning Cash Position | 194,427 | 120,616 | 153,205 | 331,798 | 194,467 |
| End Cash Position | 328,359 | 194,427 | 120,616 | 153,205 | 331,798 |
| Net Cash Flow | $133,932 | $73,811 | $-32,589 | $-178,593 | $137,331 |
| Free Cash Flow | |||||
| Operating Cash Flow | 157,719 | 16,702 | -114,035 | -125,660 | -136,166 |
| Capital Expenditure | -523 | -50 | N/A | -1,122 | -7,587 |
| Free Cash Flow | 157,196 | 16,652 | -114,035 | -126,782 | -143,753 |